The primary function of vascular networks is to transport blood and deliver oxygen and
nutrients to tissues, which occurs at the interface of the microvasculature. Therefore, the …

Human cardiac organoids hold remarkable potential for cardiovascular disease modeling
and human pluripotent stem cell–derived cardiomyocyte (hPSC-CM) transplantation. Here …

Although pharmacological and interventional advances have reduced the morbidity and
mortality of ischemic heart disease, there is an ongoing need for novel therapeutic strategies …

Aims Induced pluripotent stem cell (iPSC)-derived cardiovascular progenitor cells represent
a suitable autologous cell source for myocardial regeneration as they have the capability to …

Recent advances in the generation of cardiomyocytes (CMs) from human pluripotent stem
cells (hPSCs), in conjunction with the promising outcomes from preclinical and clinical …

Medium-chain length polyhydroxyalkanoates (MCL-PHAs) have demonstrated exceptional
properties for cardiac tissue engineering (CTE) applications. Despite prior work on MCL …

Myocardial infarction (MI) is one of the leading causes of death worldwide. The
complications associated with MI can lead to the formation of nonconductive fibrous scar …

Although it has been observed that aggregate size affects cardiac development, an
incomplete understanding of the cellular mechanisms underlying human pluripotent stem …

The availability of human cardiomyocytes derived from embryonic stem cells (ESCs) has
generated considerable excitement, as these cells are an excellent model system for …

Cardiovascular disease is a leading cause of death worldwide. Since adult cardiac cells are
limited in their proliferation, cardiac tissue with dead or damaged cardiac cells downstream …